J. Saccavini

发表

Neutron-irradiated antibody-functionalised carbon nanocapsules for targeted cancer radiotherapy

A. Bianco, K. Al‐Jamal, G. Tobias, 2020, Carbon.

Neutron Activated 153Sm Sealed in Carbon Nanocapsules for In Vivo Imaging and Tumor Radiotherapy.

A. Bianco, K. Al‐Jamal, G. Tobias, 2019, ACS nano.

Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab′)2 fragments

A. Perkins, R. Bares, R. Baum, 2004, European Journal of Nuclear Medicine.

Adjuvant Radioimmunotherapy Trial with Iodine-131–Labeled Anti–Carcinoembryonic Antigen Monoclonal Antibody F6 F(ab′)2 after Resection of Liver Metastases from Colorectal Cancer

M. Ychou, P. Rouanet, C. Bascoul-Mollevi, 2008, Clinical Cancer Research.

Immunoscintigraphy using 111in-labelled F(ab')2 fragments of anti-carcinoembryonic antigen (CEA) monoclonal antibody for staging of non-small cell lung carcinoma.

G. Ferretti, E. Brambilla, C. Brambilla, 1994, European journal of cancer.

Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.

P. Fumoleau, J. Chatal, C. Curtet, 1989, Cancer research.

Immunoscintigraphy of Hodgkin's disease: in vivo use of radiolabelled monoclonal antibodies derived from Hodgkin cell lines.

M. Pfreundschuh, B. Caillou, J. Lumbroso, 1990, European journal of cancer.

Radiolabeled monoclonal antibodies against Reed-Sternberg cells for in vivo imaging of Hodgkin's disease by immunoscintigraphy.

V. Diehl, M. Pfreundschuh, B. Caillou, 1989, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

ANTIBODIES IN 200 PATIENTS AND INITIAL ATTEMPTS AT RADIOIMMUNOTHERAPY

R. Baum, J. Chatal, M. Lorenz, 1986 .

Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.

J. Douillard, H. Koprowski, J. Chatal, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Biological Fate of Renal Agents

J. Saccavini, M. Villa, A. Bardy, 1986 .

2,3-Dimercaptosuccinic-acid chelates--2. Renal localization.

J. Moretti, J. Saccavini, J. Rapin, 1984, International journal of nuclear medicine and biology.

[Immunotargeting of tumors: state of the art and prospects in 2000].

B. Robert, L. Leserman, F. Buchegger, 2000, Bulletin du cancer.

Synthesis of porphyrins with pendant arms: Participation of the ancillary ligands to the complexation process in proteic medium

J. Saccavini, J. Verlhac, L. Mauclaire, 1995 .

Radioimmunoscintigraphy of CA 19-9/CEA Producing Tumors Using I-131 Labeled F(ab′) 2 Fragments of Monoclonal Antibodies (19-9/Anti-CEA Radioimmunococktail)

F. Maul, G. Hör, R. Baum, 1986 .

Imaging of myocardial infarction in dogs and humans using monoclonal antibodies specific for human myosin heavy chains.

B. Pau, J. Chevalier, C. Larue, 1991, Journal of the American College of Cardiology.

Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues.

M. Ychou, P. Rougier, F. Eschwège, 1993, European journal of cancer.

In vitro therapeutic targeting of neuroblastomas using 125I‐labelled meta‐iodobenzylguanidine

H. Métivier, J. Chatal, R. Masse, 1990, International journal of cancer.

Immunoscintigraphy of colon carcinoma.

J. Douillard, P. Fumoleau, H. Koprowski, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.

J. Chatal, J. Gestin, J. Saccavini, 1989, Cancer research.

Design and Development of Radiopharmaceuticals Based on Monoclonal Antibodies

J. Chatal, J. Saccavini, M. Kremer, 1987 .

Immunoscintigraphy of recurrences of gynecologic carcinomas.

P. Fumoleau, J. Chatal, C. Curtet, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolabeling of monoclonal antibodies.

J. Bruneau, J. Saccavini, J. Bohy, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Radiolabelled monoclonal antibodies against alpha-fetoprotein for in vivo localization of human hepatocellular carcinoma by immunotomoscintigraphy

P. Rougier, J. Lumbroso, D. Bellet, 2004, European Journal of Nuclear Medicine.

Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.

R. Pasqualini, J. Saccavini, M. Moinereau, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Gd‐25 DTPA‐MAb, a potential NMR contrast agent for MRI in the xenografted nude mouse: Preliminary studies

J. Chatal, C. Tellier, S. Akoka, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Monoclonal Antibody Labeling with Indium-111 and Gadolinium via DTPA Chelation on Selective and Nonselective Sites of the Antibody

C. Tellier, C. Curtet, J. Saccavini, 1988 .

Magnetic resonance imaging studies on nude mice grafted with colorectal adenocarcinoma using gadolinium-labeled monoclonal antibody.

C. Tellier, C. Curtet, J. Saccavini, 1988 .

A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice

D. Bourel, P. Bourguet, L. Dazord, 2004, Cancer Immunology, Immunotherapy.

2,3-Dimercaptosuccinic-acid chelates--1. Structure and pharmacokinetic studies.

J. Moretti, J. Saccavini, J. Rapin, 1984, International journal of nuclear medicine and biology.

Immunoscintigraphy using 111In-labeled F(ab')2 fragments of anticarcinoembryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma.

J. Chatal, J. Saccavini, J. Vuillez, 1992, The Journal of clinical endocrinology and metabolism.

Phase‐I/II radio‐immunotherapy study with iodine‐131‐labeled anti‐CEA monoclonal antibody F6 F(ab′)2 in patients with non‐resectable liver metastases from colorectal cancer

J. Rossi, M. Ychou, B. Robert, 1998, International journal of cancer.

Pharmacokinetic study of radiolabeled anti-colorectal carcinoma monoclonal antibodies in tumor-bearing nude mice

J. Douillard, H. Koprowski, J. Chatal, 2004, European Journal of Nuclear Medicine.

Comparison of SPECT imaging using monoclonal antibodies with computed tomography (CT) and ultrasonography (US) for detection of recurrences of colorectal carcinoma: A prospective clinical study

J. Douillard, J. Chatal, C. Curtet, 1985 .

Radioimmunodetection of lymph node invasion in prostatic cancer. The use of iodine 123 (123I)‐labeled monoclonal anti‐prostatic acid phosphatase (PAP) 227 A F(ab′l)2 antibody fragments in vivo

P. Teillac, A. Duc, J. Saccavini, 1989, Cancer.

Histological correlation of 17 prospective immunoscintigraphies of recurrences of colorectal carcinomas using indium-111-labeled anti-cea and(or) 19-9 monoclonal antibodies

J. Chatal, J. Saccavini, P. Lehur, 2004, European Journal of Nuclear Medicine.

Functionalization of filled radioactive multi-walled carbon nanocapsules by arylation reaction for in vivo delivery of radio-therapy.

K. Al‐Jamal, G. Tobias, T. Da Ros, 2021, Journal of materials chemistry. B.